Celltrion
068270.KS
#799
Rank
A$45.96 B
Marketcap
A$200.41
Share price
-0.50%
Change (1 day)
4.64%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): A$3.78

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$3.57. In 2025 the company made an earnings per share (EPS) of A$4.36 an increase over its 2024 EPS that were of A$1.65.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$3.78-13.28%
2025A$4.36163.66%
2024A$1.65-53.73%
2023A$3.58-2.08%
2022A$3.65-11.72%
2021A$4.142.03%
2020A$4.0582.8%
2019A$2.2218.31%
2018A$1.87-36.33%
2017A$2.94161.25%
2016A$1.132.86%
2015A$1.1017.84%
2014A$0.935.87%
2013A$0.88-70.85%
2012A$3.01134.09%
2011A$1.2943.59%
2010A$0.9074.49%
2009A$0.51317.8%
2008A$0.12-71.7%
2007A$0.43